These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16936173)

  • 1. OmniPod Insulin Management System: patient perceptions, preference, and glycemic control.
    Zisser H; Jovanovic L
    Diabetes Care; 2006 Sep; 29(9):2175. PubMed ID: 16936173
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin pump in the treatment of adult age diabetes].
    Sane T; Tulokas T; Nikkanen P; Heikkilä P; Huttunen E; Niskanen L
    Duodecim; 2005; 121(8):839-45. PubMed ID: 15931827
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pump therapy.
    Page C
    Tenn Med; 2000 Nov; 93(11):410-4. PubMed ID: 11077887
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of the Omnipod
    Polonsky WH; Hessler D; Layne JE; Zisser H
    Diabetes Technol Ther; 2016 Oct; 18(10):664-670. PubMed ID: 27673352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes mellitus in the year 1982].
    van Ballegooie E
    Ned Tijdschr Geneeskd; 1983 Jan; 127(2):41-3. PubMed ID: 6338402
    [No Abstract]   [Full Text] [Related]  

  • 7. [Unstable type I diabetes mellitus: comparative study between intensive conventional treatment and continuous subcutaneous infusion of insulin].
    Levy I; Bergua M; Esmatjes E; Halperin I; Figuerola D
    Med Clin (Barc); 1984 Oct; 83(13):525-8. PubMed ID: 6392766
    [No Abstract]   [Full Text] [Related]  

  • 8. [Type I diabetes mellitus: insulin treatment].
    Ryff AS; Berger W; Crausaz F
    Schweiz Med Wochenschr Suppl; 1994; 60():7-13. PubMed ID: 8016617
    [No Abstract]   [Full Text] [Related]  

  • 9. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicomponent system for normoglycemic insulin substitution in type 1 diabetic outpatients.
    Howorka K; Stöhr H; Thoma H; Waldhäusl W
    Life Support Syst; 1985; 3 Suppl 1():540-5. PubMed ID: 3916618
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensified insulin regimens. Should they be used in all patients with type I diabetes?
    Hollander P
    Postgrad Med; 1994 Sep; 96(3):63-8, 72. PubMed ID: 8072915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin treatment for diabetes on the day of surgery].
    Kuusisto A
    Duodecim; 1990; 106(5):415-21. PubMed ID: 1670109
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of diabetes mellitus with insulin infusions].
    Mirouze J; Selam JL; Rodier M; Lapinski H; Saeidi C; Richard JL
    Bull Acad Natl Med; 1984; 168(1-2):80-90. PubMed ID: 6383552
    [No Abstract]   [Full Text] [Related]  

  • 14. [Novel insulin products and delivery methods].
    Sipilä I; Saukkonen T
    Duodecim; 2004; 120(9):1167-72. PubMed ID: 15232860
    [No Abstract]   [Full Text] [Related]  

  • 15. No apparent local effect of insulin on microdialysis continuous glucose- monitoring measurements.
    Hermanides J; Wentholt IM; Hart AA; Hoekstra JB; DeVries JH
    Diabetes Care; 2008 Jun; 31(6):1120-2. PubMed ID: 18332157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions.
    Zisser H
    Diabetes Care; 2008 Feb; 31(2):238-9. PubMed ID: 18056889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintaining good control in children with diabetes.
    Faro B
    Pediatr Nurs; 1983; 9(5):368-73. PubMed ID: 6353343
    [No Abstract]   [Full Text] [Related]  

  • 18. [The insulin pump in type II diabetics].
    Svacina S; Masek Z; Páv J; Kábrt J; Hovorka R; Ponka J
    Vnitr Lek; 1988 Feb; 34(2):146-52. PubMed ID: 3284182
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of post-prandial insulin needs by pectin as assessed by the artificial pancreas in insulin-dependent diabetics.
    Poynard T; Slama G; Tchobroutsky G
    Diabete Metab; 1982 Sep; 8(3):187-9. PubMed ID: 6754491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.